Kahlilia C. Morris-Blanco

Kahlilia C. Morris-Blanco

Auto-generated profile, based on publicly available information

Kahlilia C. Morris-Blanco

Department of Neurological Surgery, University of Wisconsin-Madison (V.A., K.C.M.-B., S.L.M., M.K., R.V.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Stroke
Verified
Journal Article
Closed access
PDF file
ACAnil K. Chokkalla
Anil K. Chokkalla
SJSoomin Jeong
Soomin Jeong
SMSuresh L. Mehta
Suresh L. Mehta
CDCharles K. Davis
Charles K. Davis
KMKahlilia C. Morris-Blanco
Kahlilia C. Morris-Blanco
RVRaghu Vemuganti
Raghu Vemuganti
Background: FTO (fat mass and obesity-associated protein) demethylates N 6 -methyladenosine (m 6 A), which is a critical epitranscriptomic regulator of neuronal function. We previously reported that ischemic stroke induces m 6 A hypermethylation with a simultaneous decrease in FTO expression in neurons. Currently, we evaluated the functional significance of restoring FTO with an adeno-associated virus 9, and thus reducing m 6 A methylation in poststroke brain damage. Methods: Adult male and female C57BL/6J mice were injected with FTO adeno-associated virus 9 (intracerebral) at 21 days prior to inducing transient middle cerebral artery occlusion. Poststroke brain damage (infarction, atrophy, and white matter integrity) and neurobehavioral deficits (motor function, cognition, depression, and anxiety-like behaviors) were evaluated between days 1 and 28 of reperfusion. Results: FTO overexpression significantly decreased the poststroke m 6 A hypermethylation. More importantly, exogenous FTO substantially decreased poststroke gray and white matter damage and improved motor function recovery, cognition, and depression-like behavior in both sexes. Conclusions: These results demonstrate that FTO-dependent m 6 A demethylation minimizes long-term sequelae of stroke independent of sex.

19 July 2022 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
KMKahlilia C Morris-Blanco
Kahlilia C Morris-Blanco
ACAnil K Chokkalla
Anil K Chokkalla
VAVijay Arruri
Vijay Arruri
SJSoomin Jeong
Soomin Jeong
SPSamantha Probelsky
Samantha Probelsky
RVRaghu Vemuganti
Raghu Vemuganti
Accumulating evidence indicates a central role for epigenetic modifications in the progression of stroke pathology. These epigenetic mechanisms are involved in complex and dynamic processes that modulate post-stroke gene expression, cellular injury response, motor function, and cognitive ability. Despite decades of research, stroke continues to be classified as a leading cause of death and disability worldwide with limited clinical interventions. Thus, technological advances in the field of epigenetics may provide innovative targets to develop new stroke therapies. This review presents the evidence on the impact of epigenomic readers, writers, and erasers in both ischemic and hemorrhagic stroke pathophysiology. We specifically explore the role of DNA methylation, DNA hydroxymethylation, histone modifications, and epigenomic regulation by long non-coding RNAs in modulating gene expression and functional outcome after stroke. Furthermore, we highlight promising pharmacological approaches and biomarkers in relation to epigenetics for translational therapeutic applications.

1 September 2025 in Stroke
Verified
Journal Article
Closed access
VAVijay Arruri
Vijay Arruri
KMKahlilia C. Morris-Blanco
Kahlilia C. Morris-Blanco
SMSuresh L. Mehta
Suresh L. Mehta
MKMehakpreet Kaur
Mehakpreet Kaur
RVRaghu Vemuganti
Raghu Vemuganti
BACKGROUND: Epigenetic modifications 5-methylcytosine and 5-hydroxymethylcytosine in DNA regulate neuronal survival under ischemic stress. We previously showed that TET3 (ten-eleven translocase 3)–mediated 5-methylcytosine to 5-hydroxymethylcytosine conversion induces neuroprotective gene transcription after stroke. As TET3 neuronal isoform lacks the DNA-binding domain, how TET3 drives 5-hydroxymethylcytosine–mediated transcriptional induction in the ischemic brain remains unclear. Long noncoding RNAs (lncRNAs) act as structural scaffolds to recruit chromatin-modifying proteins and other RNAs to specific genomic loci. However, whether TET3 requires an lncRNA to drive DNA hydroxymethylation in the ischemic brain is unknown. METHODS: Adult male and female mice were subjected to transient middle cerebral artery occlusion. TET3-bound lncRNAs were immunoprecipitated from peri-infarct cortex, and TILR (TET3-interacting lncRNA; AK020504) identified was inhibited with small interfering RNA injected at 5 minutes of reperfusion. Ascorbate was administered at 30 minutes of reperfusion to induce TET3 activity. Poststroke DNA hydroxymethylation was assessed with hydroxymethylation DNA immunoprecipitation sequencing, and sensorimotor deficits, and infarct volume were evaluated between days 1 and 7 of reperfusion. RESULTS: TILR binds to TET3 with high affinity and was significantly upregulated in the peri-infarct cortex at 12 hours of reperfusion. Knockdown of TILR increased the infarct volume and reduced the motor function recovery after transient middle cerebral artery occlusion, in a TET3-dependent manner. On contrary, TET3 activation by ascorbate decreased brain damage and improved motor function recovery after ischemia. However, ascorbate-induced postischemic protection was abrogated by TILR knockdown. Genome-wide profiling showed that ascorbate increases the number of differentially hydroxymethylated regions in the poststroke genome, a neuroprotective effect that is reversed by TILR knockdown. Moreover, TILR inhibition significantly reduced the DNA hydroxymethylation in the intergenic regions associated with enhancers, super enhancers, and the promoters of other lncRNAs, microRNAs, and PIWI-interacting RNAs. CONCLUSIONS: These findings highlight the essential role of TILR in TET3-mediated 5-hydroxymethylcytosine-dependent epigenetic reprogramming in the ischemic brain.

5 November 2023 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
RVRaghu Vemuganti
Raghu Vemuganti
VAVijay Arruri
Vijay Arruri
KMKahlilia Morris-Blanco
Kahlilia Morris-Blanco

10 October 2026 in Trends in Neurosciences
Verified
Journal Article
Closed access
ASAbd-El-Monsif A. Shawky
Abd-El-Monsif A. Shawky
HHHui-Ting Huang
Hui-Ting Huang
DPDhruv Parikh
Dhruv Parikh
KMKahlilia C. Morris-Blanco
Kahlilia C. Morris-Blanco